Page 83 - H:\Annual Report\

Priority 2 No Preventable Harms or Deaths

Rationale The Trust has made significant improvements in reducing the amount of harm being caused
to patients, with medication errors causing harm being reduced by 75% and hospital acquired
infections being reduced by over 45%. Patient safety remains a top priority for the Trust with the
acknowledgement that there is always room for further improvement. Specific focus will be given to
early intervention when patients begin to deteriorate unexpectedly, and to reducing the number of
hospital acquired pressure ulcers.
The Trust Board agree that there should be specific focus on:
• Achieving zero preventable deaths in hospital

• Early intervention for the deteriorating patient
• Reduction in preventable pressure ulcers
Measuring The number of preventable deaths will be taken as a high level proxy for this measure. Compliance

with the national sepsis standards and the number of Grade 3 and 4 pressure ulcers will also be
measured.
Monitoring The monthly corporate report will be used to monitor and report progress against these measures.
& Reporting This is reported through to Clinical Quality Assurance Committee and Trust Board. Sepsis standards
are also reported nationally and form part of the quality contract with commissioners.

Priority 3 Outstanding Clinical Outcomes for Children

Rationale The Trust is proud to be world leading in many areas of developing paediatric outcome measures
and recognises there are further opportunities to develop and improve our monitoring of clinical
outcomes. Part of this commitment links to the Trust’s desire to reduce variation and to strengthen
standardisation of clinical pathways, thereby ensuring the best evidence based pratice is embedded
and spread across the organisation. As a Global Digital Exemplar, the Trust is already committed
to digitising clinical pathways and standardising documentation, using best practice as evidenced
in NICE guidance and National Standards. This will form part of our priority to deliver outstanding
clinical outcomes for children. Specific focus will also be given to further reducing hospital acquired
infections as a key measure of improved clinical outcome.
The Trust Board agree that there should be specific focus on:
• Developing digitised clinical pathways

• Developing and improving outcomes in each specialty
• Reduction in hospital acquired infections
Measuring The Trust will track the number of standardised / digitised pathways, plus bespoke outcome
measures in each specialty. The number of hospital infections will also be used to demonstrate
improvement in clinical outcomes.
Monitoring Evidence based, digitised care pathways will continue to be monitored through the bespoke Global
& Reporting Digital Excellence Steering Group and reported to the Trust’s Programme Board. Hospital Acquired

Infections will be closely monitored by the Trust’s Infection Prevention and Control team and tracked
monthly through the Trust’s corporate report, reporting ultimately to Clinical Quality Assurance
Committee and Trust Board.

Alder Hey Children’s NHS Foundation Trust 83 Annual Report & Accounts 2017/18